(26) developed a diagnostic panel consisting of SOX2OT, ANRIL, CEA, CYFRA21-1, and SCCA, which could be valuable in NSCLC diagnosis (sensitivity = 77.1%, specificity = 79.2%). The gene discussed is CDKN2B-AS1; the disease is non-small cell lung carcinoma.